Company Profile (AI Text)
Name: Biomedican inc
Canonical URL: https://wefunder.com/biomedican_inc
Updated at: 2026-06-02T05:00:54Z

Tagline: Producing medical-grade cannabis more efficiently
Elevator pitch: Biosynthesis platform to produce 99% pharmaceutical grade cannabinoids, organic, 100% identical to natural cannabinoids at 70-90less cost using 90% less natural resources

Key claims:
- Total raised on Wefunder: 220467 | citation: https://wefunder.com/biomedican_inc#claim-total-raised
- Total investors: 163 | citation: https://wefunder.com/biomedican_inc#claim-total-investors

Verified facts:
- Total raised on Wefunder: 220467 | observed_at: 2026-06-02T05:00:54Z | expires_at: 2026-06-03T05:00:54Z
- Total investors: 163 | observed_at: 2026-06-02T05:00:54Z | expires_at: 2026-06-03T05:00:54Z

Computed metrics:
- total_amount_raised: 220467
- total_investors: 163
- team_size: 6
- featured_investor_count: 1
- faq_count: 5
- recent_post_count: 10

Quick facts:
- Medical-use, non-GMO cannabinoids for 70-90% less than current, wholesale prices | citation: https://wefunder.com/biomedican_inc#claim-fact-1
- Costs less than $1/gram per cannabinoid using 90% less resources; 4 patents pending | citation: https://wefunder.com/biomedican_inc#claim-fact-2
- 70+ press mentions; Forbes, Bloomberg, Nasdaq, Reuters, Maxim, Rolling Stones | citation: https://wefunder.com/biomedican_inc#claim-fact-3
- Partnered with Institute of Genetics Moscow, Demark Technical University, Imperial College UK | citation: https://wefunder.com/biomedican_inc#claim-fact-4
- CBG reduces pain, inflammation; treats Glaucoma, Huntington's disease, IDB | citation: https://wefunder.com/biomedican_inc#claim-fact-5
- THCV helps with diabetes, inflammation, neuroprotection, & bone growth | citation: https://wefunder.com/biomedican_inc#claim-fact-6
- One of the fastest growing markets in the world; expected to reach $25B in 2025 | citation: https://wefunder.com/biomedican_inc#claim-fact-7

FAQ:
- Q: Hello. Would it be possible to get more details about what your advantages are compared to potential competitors such as Demetrix and Cronos group? It seems these other companies also use yeast. What are you doing differently and why do you think it would give you an edge over...
  A: The information about each competitor is limited and our judgment is coming from publicly available information. The point below could be wrong due to limited information to the current stage of R&D by competitors. Demetrix: 1. they are using a baker's yeast (Saccharomyces cerevisiae) for production which has significantly fewer precursors (Acetyl-CoA). 2. They are using gene csPT4 for the production of CBGA. This gene is not specific. It is producing not only CBGA but also sesqui-CBGA. 3...
- Q: Does your company operate in a cGMP or better manufacturing facility? What is the size is the facility you are using for manufacturing, labs, R&D etc?
  A: we are not in the production stage yet. We don't have cGMP facility yet. We are using 8,000 sqft facility in Fremont, CA. Once we begin large scale production in early 2022 it will be in a GMP certified facility
- Q: Where can I find your SEC filings? Financial Information?
  A: We have just filed with the SEC. The financial info will be available in the next couple of days. I will update you once it's public.
- Q: Can't find it anywhere , what's the per share cost?
  A: The share price is $4.50. We are hoping and planning on going public next year at a much higher price. 10-15 dollars but there are no guarantees that we will be able to do so. We are very confident though
- Q: Hi team, I'm interested in investing $10k in this project but could you elaborate a bit on what the investors get in return for their investment? Is it a convertible note or what tool? thanks!
  A: The share price is $4.50. We are hoping and planning on going public next year at a much higher price. 10-15 dollars but there are no guarantees that we will be able to do so. We are very confident though.

Recent posts:
- Dennis O'Neill President Biomedican Interview on Cannabis Capital (2021-09-21T20:14:29Z) https://wefunder.com/feed/148664
- The Bio Revolution of Medical Cannabinoid Therapeutics (2021-09-13T13:03:20Z) https://wefunder.com/feed/148185
- BioMedican; Leading Technology Overview Video (2021-08-30T18:59:21Z) https://wefunder.com/feed/147871
- Biomedican Receives Approval Notice of it's 1st Patent (2021-08-20T12:48:03Z) https://wefunder.com/feed/147524
- Cannabis Connect BioMediCan Interview (2021-08-09T14:33:46Z) https://wefunder.com/feed/147497
- Cannabis Therapeutics for Health and Wellness with Dennis O’Neill (2021-08-03T16:18:15Z) https://wefunder.com/feed/147346
- The Future of Products Containing Rare Cannabinoids in Pharmacies (2021-07-30T15:00:01Z) https://wefunder.com/feed/147240
- Biosynthesis of Rare Cannabinoids has led to a Gold Rush on Investment due to the Therapeutic Potential (2021-07-30T14:55:50Z) https://wefunder.com/feed/147239
- Interview the Difference between CBD and Rare Cannabinoids (2021-07-30T14:50:31Z) https://wefunder.com/feed/147238
- Biomedican Receives Approval Notification From the U.S. Patent Office on Its 1st Patent https://www.prnewswire.com/news-releases/biomedican-receives-approval-notification-from-the-us-patent-office-on-its-1st-patent-301342394.html (2021-07-30T14:45:38Z) https://wefunder.com/feed/147145